Incyte Corp (NASDAQ:INCY)

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

Big Pharma and Big Biotech sometimes live and die by actions out of the U.S. Food and Drug Administration (FDA). For Eli Lilly and Co. (NYSE: LLY) and Incyte Corp. (NASDAQ: ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Canadian Solar, Constellation Brands, Eli Lilly, Incyte, McDonald’s, Snap and More

Stocks were indicated up about 0.1% in Dow and S&P futures on Monday, with light market participation from some European markets after Easter. The bull market may be more than ...
Read Full Story »

Analysts See 10 Companies Beating Expectations This Earnings Season

With earnings starting to really snowball next week, and a market that seems to be teetering somewhat due to high valuations and some messy geopolitical issues, it makes sense for ...
Read Full Story »

Jefferies Thinks 3 Red-Hot Biotech Stocks Can Beat Q1 Estimates

If any industry has been under pressure over the past year or so, it has been biotechnology. While there are some positives for the industry, it still faces some definite ...
Read Full Story »

The 5 Best Performing S&P 500 Stocks for Q1

Between the November election and the end of 2016, the S&P 500 index gained 4.6%. Since the beginning of 2017, the index has added another 5.53%. The so-called Trump bump ...
Read Full Story »

Top-Performing S&P 500 Stocks Already Showing Gains of 30% to 50% in 2017

With eight days of selling in the broader stock market, a feat not recorded since 2011, many investors may be worried that the Trump-bump post-election rally might be over. Time will ...
Read Full Story »

What a Combined Gilead and Incyte Would Look Like

Gilead Sciences Inc. (NASDAQ: GILD) has long been in need of a catalyst to move its business, and a lot of investors and analysts alike have considered this company dead ...
Read Full Story »
Profit or Loss

Top 5 Earnings to Look For on Tuesday

The most recent earnings season is coming to a close, and the broad markets are pushing even higher with the Dow, Nasdaq and S&P 500 hitting new highs within the ...
Read Full Story »
Handshake

Why This Collaboration Is So Important for Calithera

Shares of Calithera Biosciences Inc. (NASDAQ: CALA) saw a solid gain early on Monday after the company reported a global collaboration and licensing agreement with Incyte Corp. (NASDAQ: INCY). Ultimately, this ...
Read Full Story »
Good heart health

Why Credit Suisse Sees Incyte Rising Over 15%

Incyte Corp. (NASDAQ: INCY) is one of the health care stocks that hit it big in 2016 — that is, after it crashed and burned. As we all know, 2016 ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Ally, IBM, MetLife, Qualcomm, Verizon, Williams, Incyte and Many More

Stocks have pulled back off their highs from the end of 2016 and that Dow Jones Industrial Average (DJIA) 20,000 mark remains elusive. The major market indexes were indicated a ...
Read Full Story »
Test tubes

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

Needless to say, the past two years have been rough on biotech. So rough in fact, that a basket of the largest capitalization stocks now trades with a price-to-earnings growth ...
Read Full Story »
bigger fish

These 5 Biotech Stocks Could Be Big Takeover Targets in 2017

After a very tough year for the biotech stocks last year, they initially jumped after the election of Donald Trump as investors hoped that the rhetoric on drug pricing would ...
Read Full Story »
bigger fish

3 Biotech Stocks Could Be the Next Big Takeover Targets

Just as the biotech segment was starting to regain lost ground, and was fast approaching 2016 highs, yet another speed bump was hit. The EpiPen controversy, and the resulting commentary again ...
Read Full Story »
Doctor, Health (pulse) copy

Analysts Very Positive on 3 Top Stocks Following Jefferies Healthcare Conference

If it’s summertime then it is Wall Street conference time, because when the weather heats up so does the conference schedule. With the Jefferies Healthcare Conference wrapping up in New ...
Read Full Story »